5-Aminolevulinic Acid

ATC — · 4 markets · 4 records

5-Aminolevulinic Acid 4 markets · 4 records Forms

AU 1 records · 1 strengths

Records without a stated strength · 1 ALACARE

TW 1 records · 1 strengths

Records without a stated strength · 1 Gliolan Powder for Oral Solution、格麗藍口服溶液用粉劑

HK 1 records · 1 strengths

Records without a stated strength · 1 GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 GLIOLAN

Side-by-side table

Strength / form / release	AU	TW	HK	EU
not disclosed unknown	ALACARE	not recorded	GLIOLAN, POWDER FOR ORAL SOLUTION, 30 MG/ML	GLIOLAN
not disclosed powder	not recorded	Gliolan Powder for Oral Solution 格麗藍口服溶液用粉劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.